Accredited Research Group in Hematology and Hemotherapy, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Department of Hematology, Hospital Universitario y Politécnico La Fe, Barcelona, Spain.
Front Immunol. 2021 Mar 31;12:625591. doi: 10.3389/fimmu.2021.625591. eCollection 2021.
Chédiak-Higashi syndrome (CHS) is a rare autosomal recessive (AR) immune disorder that has usually been associated to missense, nonsense or indels mutations in the gene. In this study, we describe for the first time the case of a CHS patient carrying a homozygous mutation in the gene inherited as a result of a partial uniparental isodisomy (UPiD) of maternal origin. Sanger sequencing of the cDNA and single nucleotide polymorphism (SNP)-arrays were performed to identify the causative mutation and to explain the molecular mechanism of inheritance, respectively. Partial-UPiD leads to a copy neutral loss of heterozygosity (CN-LOH) of the telomeric region of chromosome 1 (1q41q44), unmasking the potential effect of the mutation detected. The mutation (c.8380dupT) is an insertion located in exon 32 of the gene resulting in a premature stop codon and leading to the loss of all the conserved domains at the C-terminal of the LYST protein. This would account for the severe phenotype observed. We also reviewed the only two previously reported cases of CHS as a result of a uniparental disomy. In this study, we show that the combination of different strategies, including the use of SNP-arrays, is pivotal to fine-tune the diagnosis of rare AR disorders, such as CHS. Moreover, this case highlights the relevance of uniparental disomy as a potential mechanism of CHS expression in non-consanguineous families.
Chédiak-Higashi 综合征(CHS)是一种罕见的常染色体隐性(AR)免疫疾病,通常与 基因中的错义、无义或插入缺失突变有关。在这项研究中,我们首次描述了一例 CHS 患者,其携带 基因的纯合突变,该突变是由于母源单亲二体性(UPiD)的部分遗传所致。对 cDNA 进行 Sanger 测序,并进行单核苷酸多态性(SNP)-array 分析,分别用于鉴定致病突变和解释遗传的分子机制。部分 UPiD 导致 1 号染色体(1q41q44)端粒区域的拷贝中性杂合性丢失(CN-LOH),揭示了检测到的突变的潜在影响。该突变(c.8380dupT)是位于 基因外显子 32 中的插入,导致提前终止密码子,并导致 LYST 蛋白 C 末端所有保守结构域的丢失。这可以解释观察到的严重表型。我们还回顾了之前报道的两例由于单亲二体性导致的 CHS 病例。在这项研究中,我们表明,包括使用 SNP-array 在内的不同策略的组合,对于微调 CHS 等罕见 AR 疾病的诊断至关重要。此外,该病例强调了单亲二体性作为非近亲家庭中 CHS 表达的潜在机制的重要性。